Shareholders Equity: The sum of preferred and common equity items.
Bora Pharmaceuticals Co., Ltd. - Sponsored ADR (BORAY) had Shareholders Equity of $560.86M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$610.35M |
|
$95.70M |
|
$358.27M |
|
$252.08M |
|
$504.63M |
|
$105.72M |
|
$63.70M |
|
$169.42M |
|
$169.42M |
|
$142.78M |
|
$142.78M |
|
$97.78M |
|
$142.78M |
|
$105.72M |
|
$140.60M |
|
623.78M |
|
678.68M |
|
$0.15 |
|
$0.15 |
|
| Balance Sheet Financials | |
$620.74M |
|
$334.91M |
|
$814.59M |
|
$1.44B |
|
$427.60M |
|
$378.66M |
|
$446.87M |
|
$874.47M |
|
$560.86M |
|
$360.41M |
|
|
Shareholders Equity |
$560.86M |
634.94M |
|
| Cash Flow Statement Financials | |
$144.57M |
|
$-108.49M |
|
$-44.20M |
|
$187.12M |
|
$162.97M |
|
$-24.15M |
|
$2.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.45 |
|
-- |
|
-- |
|
0.40 |
|
1.00 |
|
41.30% |
|
17.32% |
|
17.32% |
|
23.04% |
|
27.76% |
|
15.68% |
|
$123.30M |
|
-- |
|
-- |
|
-- |
|
0.43 |
|
3.27 |
|
2.08 |
|
175.35 |
|
25.46% |
|
39.62% |
|
9.95% |
|
15.20% |
|
$0.88 |
|
$0.18 |
|
$0.21 |
|